The PSF and MTF Biologics offer research grants to investigators studying allograft tissue transplantation in plastic and reconstructive surgery. These grants are intended to provide support for research projects focused on biologic repair and reconstruction with a strong clinical translation component that utilize dermal, adipose, placental or other allograft transplant technologies. Proposed studies should focus on novel translational and clinical research in the fields of tissue allograft transplantation and science, novel uses of allografts, combination with other biomaterials to enhance properties, and transformative regenerative medicine technologies relying on allograft tissues and matrices. However, proposals focusing solely on autologous grafts and synthetic applications that do not incorporate investigation of allograft use and/or grant proposals where the allograft is solely a scaffold for autograft materials (including cells) are beyond the scope of this award.

The PSF and MTF Biologics offer research grants for projects with a high likelihood of impact on scientific discipline and/or on patient care. Both clinical and basic science research projects will be considered for submission. Examples of clinical technologies of interest include but are not limited to the use of allograft biologics in breast reconstruction, wound healing, nose reshaping, soft tissue defect filling, allograft in fat transplantation and injection, use of allograft in tissue engineering or bioprinting, and other applications of allograft tissue in plastic and reconstructive surgery. Clinical evaluation of allograft tissues will also be considered for funding, following the same scientific topics and technologies previously described.

Deadline: Dec. 1, 2022